275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2021. Parexel International Corporation.
At this stage, the right data will show regulators and investors that your new molecule is effective and ready to progress. Therefore, access to focused support is critical to generating relevant data.
Phase II is sometimes broken down further into Phase IIa and Phase IIb. During Phase IIa clinical trials, we are specifically focused on determining dosage requirements. A group of patients is administered the drug in various quanitites to investigate dosage and optimal frequency of doses.
Phase IIb trials are specifically focused on testing the efficacy of the drug and determining how successful it is in terms of treatment, prevention, and diagnosing a disease.
Our early product development team delivers Phase 2a clinical trials by offering the speed and dexterity of transnational medicine experts, while also being supported by a global scientific, regulatory, and clinical organization.
Parexel FSP: Highly skilled people, where and when you need them
Watch Now
Decentralized Clinical Trials and Patient Needs
Watch Now
Genomics & biomarkers: Answers in the blood
Watch Now
Innovating for the Future of Drug Development
View Now
FSP Infographic
View Now
COVID-19 The Great Decentralized Clinical Trials Accelerator
View Now
Getting real-world data into clinical research
View Now
Making rare disease drug development personal
View Now
EMWA Regulatory Matters Vol 29 Issue 1 March 2020 - J Wolfe and S Takidar
View Now
The Rise of FSP Outsourcing
View Now
Q&A: The Evolving Role of Technology in Clinical Trials
View Now
FSP future view: the functional service provider model in 2025
View Now
Parexel FSP Culture Map
View Now
Successful wearable device selection within the clinical trials industry
View Now
Case study: A specialized team for a complex biostatistics challenge
View Now
Decentralized Clinical Trials brochure
View Now
The Evolution of FSP Article
View Now
FSP Case Study: Urgent medical writing need to assist with dual FDA submissions
View Now
Bringing clinical trials to patients with the decentralized model
View Now
Industry Perspectives on Decentralized Clinical Trials
View Now
A multi-pronged and customized approach to rare disease clinical trial patient identification and recruitment
View Now
2020 Pediatric Perceptions & Insights Study
View Now
APAC RWD and RWE Article
View Now
Q&A: Site and Patient Engagement
View Now
Patient Sensors Solution Factsheet
View Now
Using sensor technology to deploy Decentralized Clinical Trials and improve patient care
Read Now
Patient registries: Defining the patient
Watch Now
Innovation: Today’s patients, tomorrow’s medicines
Watch Now
Patient registries: Defining the patient
Watch Now
We are always available for a conversation.